Dispatches from HIE 2010
Tate & Lyle pulls plug on prebiotic Stalactis Madrid launch
Tate & Lyle has postponed the launch of its new digestive health ingredient Stalactis due to the uncertain EU regulatory environment.
News, Analysis & Insights on Nutrition, Supplements, and Health
Dispatches from HIE 2010
Tate & Lyle has postponed the launch of its new digestive health ingredient Stalactis due to the uncertain EU regulatory environment.
Consuming an antioxidant-rich beverage may reduce levels of the amino acid homocysteine, and counter the detrimental inflammatory effects associated with Alzheimer’s disease, suggests a new study.
Dispatches from HIE 2010
The world’s two biggest herbal extract suppliers respond to the recent European Commission decision to temporarily remove botanicals from the European Union health claims process.
Pomegranate juice may reduce complications in kidney disease patients on dialysis, including the high morbidity rate due to infections and cardiovascular events, according to a preliminary study.